Literature DB >> 3989958

Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.

J R Livengood, T G Sigler, L R Foster, J G Bobst, D E Snider.   

Abstract

The choice of effective preventive treatment for persons exposed to Mycobacterium tuberculosis resistant to isoniazid is uncertain. Although no data document the efficacy of any drug other than isoniazid for preventive treatment of tuberculosis, rifampin, with or without ethambutol, has been used for prophylaxis in contacts of cases with known isoniazid-resistant organisms. This report describes a community outbreak of isoniazid-resistant tuberculosis infection and a case of rifampin prophylaxis failure with acquired rifampin resistance. This raises concern about the efficacy of rifampin for the preventive treatment of contacts exposed to isoniazid-resistant tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989958     DOI: 10.1001/jama.253.19.2847

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  A relook at preventive therapy for tuberculosis in children.

Authors:  Varinder Singh; Soumya Patra
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

2.  "Shotgunning" in a population of patients with severe mental illness and comorbid substance use disorders.

Authors:  Christopher Welsh; Richard Goldberg; Stephanie Tapscott; Deborah Medoff; Stanley Rosenberg; Lisa Dixon
Journal:  Am J Addict       Date:  2012 Mar-Apr

Review 3.  Isoniazid-resistant tuberculosis: a cause for concern?

Authors:  H R Stagg; M C Lipman; T D McHugh; H E Jenkins
Journal:  Int J Tuberc Lung Dis       Date:  2017-02-01       Impact factor: 2.373

4.  Reply to Hong-min et al.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2015-09-23       Impact factor: 9.079

5.  Tuberculosis knowledge among New York City injection drug users.

Authors:  H Wolfe; M Marmor; R Maslansky; S Nichols; M Simberkoff; D Des Jarlais; A Moss
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

6.  Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea.

Authors:  J H Lee; J H Chang
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

7.  Seizures in an immunocompromised adolescent: a case report.

Authors:  Vipula R Bataduwaarachchi; Nirmali Tissera
Journal:  J Med Case Rep       Date:  2015-08-28

8.  Cannabis use and the risk of tuberculosis: a systematic review.

Authors:  Clare E French; Caroline M Coope; Luke A McGuinness; Charles R Beck; Sophie Newitt; Lauren Ahyow; Matt Hickman; Isabel Oliver
Journal:  BMC Public Health       Date:  2019-07-27       Impact factor: 3.295

9.  Current management options for latent tuberculosis: a review.

Authors:  Brianna L Norton; David P Holland
Journal:  Infect Drug Resist       Date:  2012-11-29       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.